Access to cancer treatment: a study of medicine pricing issues with recommendations for improving access to cancer medication
… $8.3bn)24) Novo Nordisk had done the same for insulin.… No, because we did not develop this product for the Indian … battle in the Indian courts, the Supreme Court of India on 1 April …..... Read More